Josh Knight

A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes

An Tran-Duy, Josh Knight, Andrew J Palmer, Dennis Petrie, Tom WC Lung, William H Herman, Bjorn Eliasson, Ann-Marie Svensson, Philip M Clarke

Journal article  |  2020  |  Diabetes Care

OBJECTIVE: To develop a patient-level simulation model for predicting lifetime health outcomes of patients with type 1 diabetes an..

Preoperative opioid use and complications following total joint replacement: a protocol for a systematic review and meta-analysis.

Cade Shadbolt, Daniel Gould, Ximena Camacho, Josh Knight, Siddharth Rele, Sharmala Thuraisingam, Yuting Zhang, Michelle M Dowsey, Peter Fm Choong

Journal article  |  2020  |  BMJ Open

INTRODUCTION: Mounting evidence now indicates that preoperative opioid use is associated with an array of complications following ..

Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians

A Tran-Duy, Robyn McDermott, Josh Knight, Xinyang Hua, Elizabeth LM Barr, Kerry Arabena, Andrew Palmer, Philip Clarke

Journal article  |  2020  |  Heart, Lung and Circulation

Background: Cardiovascular disease (CVD) is the leading cause of death for Indigenous Australians. There is widespread belief that..

Liquid gold: the cost-effectiveness of urine sample collection methods for young precontinent children

Jonathan Kaufman, Andrew Joshua Knight, Penelope A Bryant, Franz E Babl, Kim Dalziel

Journal article  |  2020  |  Archives of Disease in Childhood

BACKGROUND: Urinary tract infection (UTI) is a common childhood infection. Many febrile children require a urine sample to diagnos..

QUality improvement in primary care to prevent hospitalisations and improve Effectiveness and efficiency of care for people Living with coronary heart disease (QUEL): protocol for a 24-month cluster randomised controlled trial in primary care

Julie Redfern, Nashid Hafiz, Karice Hyun, Andrew Knight, Charlotte Hespe, Clara K Chow, Tom Briffa, Robyn Gallagher, Christopher Reid, David L Hare, Nicholas Zwar, Mark Woodward, Stephen Jan, Emily R Atkins, Tracey-Lea Laba, Elizabeth Halcomb, Laurent Billot, Tracey Johnson, Timothy Usherwood

Journal article  |  2020  |  BMC FAMILY PRACTICE

BACKGROUND: Cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke, is the leading cause of death and dis..

Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk

Nhung Nghiem, Josh Knight, Anja Mizdrak, Tony Blakely, Nick Wilson

Journal article  |  2019  |  SCIENTIFIC REPORTS

Cardiovascular disease (CVD) is the leading cause of death internationally. We aimed to model the impact of CVD preventive double ..

A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy

Max Catchpool, Jay Ramchand, Melissa Martyn, David L Hare, Paul A James, Alison H Trainer, Josh Knight, Illias Goranitis

Journal article  |  2019  |  Genetics in Medicine

PURPOSE: To assess the relative cost-effectiveness of cascade genetic testing in asymptomatic relatives of patients with dilated c..

Opioid use prior to elective surgery is strongly associated with persistent use following surgery: an analysis of 14 354 Medicare patients

Max Catchpool, Josh Knight, Jesse T Young, Philip Clarke, Michael J Barrington, Peter FM Choong, Michelle M Dowsey

Journal article  |  2019  |  ANZ JOURNAL OF SURGERY

BACKGROUND: Persistent opioid use following total joint replacement (TJR) surgery is common; however, the association between pre-..

MODELLING PROGRESSION OF RISK FACTORS IN PATIENTS WITH TYPE 1 DIABETES: TOWARDS THE MOST APPROPRIATE FUNCTIONAL FORMS FOR A SIMULATION MODEL OF LONG-TERM HEALTH OUTCOMES

A Tran-Duy, J Knight, AJ Palmer, B Eliasson, AM Svensson, PM Clarke

Conference Proceedings  |  2019  |  Value in Health

Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk

Chris Schilling, Josh Knight, Duncan Mortimer, Dennis Petrie, Philip Clarke, John Chalmers, Andrew Kerr, Rod Jackson

Journal article  |  2017  |  HEALTH POLICY